Outcome of Thromboembolic Events and Its Influence on Survival Time of Advanced NSCLC Patients Treated with Antiangiogenic Therapy.
Wei-Fan OuPei-Ya LiaoYu-Wei HsuYen-Hsiang HuangKuo-Hsuan HsuJeng-Sen TsengGee-Chen ChangTsung-Ying YangPublished in: Cancer management and research (2023)
Owing to the different risk factors and influences on the survival time, TE with and without PD may be two different disease entities.